Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2014American Journal of HematologyOpen Access

Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio‐geo‐demographic factors in the era of novel agents

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMohammed Al‐HamadaniJohn Hunter HospitalSHShahrukh K. HashmiMayo ClinicRGRonald S. GoMayo Clinic

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Al‐Hamadani et al. (2014) studied this question.

synapsesocial.com/papers/6a63a19a809dd4a9e2c1ed58https://doi.org/10.1002/ajh.23753
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial1998 · 539 citations
  2. 2Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma2013 · 113 citations
  3. 3Have drug combinations supplanted stem cell transplantation in myeloma?2012 · 9 citations
  4. 4Have drug combinations supplanted stem cell transplantation in myeloma?2012 · 14 citations
  5. 5Access to hematopoietic stem cell transplantation2010 · 149 citations